News

CHDS faculty Nicole Campos and a team of researchers at the National Cancer Institute (NCI), including Principal Deputy Director of the NCI Douglas Lowy, Senior Investigator Mark Schiffman, and

Determining whether and how to control environmental hazards raises many challenging questions related to understanding the risks and the benefits and costs of controls. In this new

Doctoral students Jacob Jameson, Skye Yoden, and Yu Li (Lily) Hsieh presented at the 2024 INFORMS Annual Meeting held in Seattle in October. Hosted by the Institute

CHDS faculty Sue J. Goldie and Stéphane Verguet served on The Lancet  Commission on Investing in Health, which recently released Global Health 2050: The Path to Halving Premature Death by

Understanding who gains and who loses from policy interventions is essential to sound decision-making. However, assessing the distributional equity of policy impacts is very challenging.

CHDS’ Soroush Saghafian, his lab, the Public Impact Analytics Science Lab (PIAS-Lab), and the Dana Farber Cancer Institute recently received a grant from the Department of Defense (DOD)

In a study recently published in Lancet Public Health, CHDS faculty Nicolas Menzies and first author Mathilda Regan, a Postdoctoral Fellow in the Department of Global Health and Population,

Beate Jahn, PhD, long term visitor and CHDS collaborator, was named 2024 President-elect of the Society for Medical Decision Making in the recent election for 2024 – 2025 Officers and Trustees.

CHDS’ Stéphane Verguet and colleagues recently published in Nature Medicine that reducing preventable deaths from major noncommunicable diseases (NCDs) and injuries around the world

In a recent study, CHDS’ Nicolas Menzies and colleagues used mathematical modelling to quantify the potential health impact and cost-savings for a hypothetical pan-tuberculosis regimen